ICU Selling And Marketing Expenses from 2010 to 2025

ICUI Stock  USD 140.16  4.12  2.86%   
ICU Medical's Selling And Marketing Expenses is decreasing with slightly volatile movements from year to year. Selling And Marketing Expenses is predicted to flatten to about 85.5 K. For the period between 2010 and 2025, ICU Medical, Selling And Marketing Expenses quarterly trend regression had mean deviation of  38,118,961 and range of 81.3 M. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2010-12-31
Previous Quarter
90 K
Current Value
85.5 K
Quarterly Volatility
40.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 276.2 M, Interest Expense of 111.9 M or Total Revenue of 2.5 B, as well as many indicators such as Price To Sales Ratio of 1.51, Dividend Yield of 0.0 or PTB Ratio of 3.58. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
  
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Latest ICU Medical's Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of ICU Medical over the last few years. It is ICU Medical's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Slightly volatile
   Selling And Marketing Expenses   
       Timeline  

ICU Selling And Marketing Expenses Regression Statistics

Arithmetic Mean30,592,719
Geometric Mean1,214,530
Coefficient Of Variation132.91
Mean Deviation38,118,961
Median100,000
Standard Deviation40,660,225
Sample Variance1653.3T
Range81.3M
R-Value(0.84)
Mean Square Error520.9T
R-Squared0.71
Significance0.000046
Slope(7,175,629)
Total Sum of Squares24798.8T

ICU Selling And Marketing Expenses History

202585.5 K
202490 K
2016100 K

About ICU Medical Financial Statements

Investors use fundamental indicators, such as ICU Medical's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Selling And Marketing Expenses90 K85.5 K

Currently Active Assets on Macroaxis

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Earnings Share
(4.84)
Revenue Per Share
97.673
Quarterly Revenue Growth
0.071
Return On Assets
0.0142
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.